Company Description
Emergent Health (OTC Link: EMGE) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $42.7K.
EMGE stock has declined 88.9% over the past year. Shares last traded at $0.0001.
This page provides a comprehensive overview of EMGE stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Emergent Health (EMGE) stock last traded at $0.0001. Over the past 12 months, the stock has lost 88.9%. At a market capitalization of $42.7K, EMGE is classified as a micro-cap stock with approximately 427.0M shares outstanding.
Latest News
Emergent Health has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 4 with negative movement. Key topics include acquisition, management. View all EMGE news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Emergent Health (EMGE) currently stands at 92.8 thousand shares.
Days to Cover History
Days to cover for Emergent Health (EMGE) currently stands at 1.0 days, down 57.8% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
EMGE Company Profile & Sector Positioning
Emergent Health (EMGE) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing EMGE often look at related companies in the same sector, including Onassis Holdings Corp (ONSS), Veritas Farms (VFRM), Viaderma (VDRM), Pineapple Express Cannabis Co (PNXP), and Real Brands (RLBD). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate EMGE's relative position within its industry.